Showing results (181-190 of 263) with videos related to

Sort By:
Pageof 27
American Journal of Clinical Pathology|November 14, 2002
Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue NetworkScott D Jewell, Mythily Srinivasan, Linda M McCart, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1986
Cyclosporin prophylaxis induces long-term prevention of diabetes, and inhibits lymphocytic infiltration in multiple target tissues in the high-risk BB ratM A Jaworski, L Honore, L D Jewell, et al.
Journal of Medical Genetics|October 3, 1999
Contribution of the MHC region to the familial risk of coeliac diseaseS Bevan, S Popat, C P Braegger, et al.
Mucosal Immunology|September 26, 2013
Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cellsM Scurr, K Ladell, M Besneux, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1993
Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritisF Sitas, R Smallwood, D Jewell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28Mythily Srinivasan, Ingrid E Gienapp, Scott S Stuckman, et al.
Transplantation|June 7, 2003
Intestinal decontamination using povidone-iodine compromises small bowel storage qualityDavid W Olson, Shin Kadota, Anthony Cornish, et al.
Clinical Immunology and Immunopathology|August 1, 1991
Lymphocyte subset reference ranges in adult CaucasiansT Reichert, M DeBruyère, V Deneys, et al.
European Journal of Human Genetics : EJHG|August 31, 2001
Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)B Dechairo, C Dimon, D van Heel, et al.
The New England Journal of Medicine|August 6, 1998
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study GroupO O Thomsen, A Cortot, D Jewell, et al.
Pageof 27